Genetic data and electronic health records: A discussion of ethical, logistical and technological considerations

Journal of the American Medical Informatics Association

Volumn 21, Issue 1, 2014, Pages 171-180

  Shoenbill, Kimberly ^a,b   Fost, Norman ^a,b   Tachinardi, Umberto ^b   Mendonca, Eneida A ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; PROTEIN;

CLINICAL DECISION MAKING; COMPUTER LANGUAGE; DECISION SUPPORT SYSTEM; DIAGNOSTIC IMAGING; DIGITAL IMAGING AND COMMUNICATIONS IN MEDICINE; DNA SEQUENCE; ELECTRONIC MEDICAL RECORD; FOLLOW UP; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC DATABASE; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; GENOME; GOVERNMENT; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFORMED CONSENT; MEDICAL ETHICS; MEDICAL INFORMATICS; MEDICAL INFORMATION; MENTAL HEALTH; ORGANIZATION AND MANAGEMENT; PATIENT INFORMATION; PERSONALIZED MEDICINE; RESEARCH; REVIEW; TECHNOLOGY;

ELECTRONIC HEALTH RECORDS; ETHICS, MEDICAL; GENOMICS; INDIVIDUALIZED MEDICINE; MEDICAL INFORMATICS;

ELECTRONIC HEALTH RECORDS; GENETIC TESTING; GENOMICS; HUMANS; MEDICAL INFORMATICS;

EID: 84890526744     PISSN: 10675027     EISSN: 1527974X     Source Type: Journal    
DOI: 10.1136/amiajnl-2013-001694     Document Type: Review

References (153)

1. Lose EJ. The emerging role of primary care in genetics. Curr Opin Pediatr 2008;20:634-8.
2. National Research Council (US). Committee for the Study of Inborn Errors of Metabolism, Genetic Screening: programs, principles and research/Committee for the Study of Inborn Errors of Metabolism, Division of Medical Sciences, Assembly of Life Sciences, National Research Council. Washington, DC: National Academy of Sciences, 1975.
3. Simopoulos AP. Genetic screening: programs, principles, and research-thirty years later. Reviewing the recommendations of the Committee for the Study of Inborn Errors of Metabolism (SIEM). Public Health Genomics 2009;12:105-11.
4. Andermann A, Blancquaert I, Beauchamp S, et al. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull WHO 2008;86:317-19.
5. Andrews LB. Assessing genetic risks: implications for health and social policy. National Academies Press, 1994.
6. Botkin JR, Clayton EW, Fost NC, et al. Newborn screening technology: proceed with caution. Pediatrics 2006;117:1793-9.
7. HIMSS. [1 August 2012]. http://www.himss.org/ASP/topics clinicalDecision.asp.
8. Human Genome Project Information, Genome Glossary. [1 August, 2012]. http:// genomics.energy.gov.
9. US Food and Drug Administration. [23 July 2012]. http://www.fda.gov/ MedicalDevices/DeviceRegulationandGuidance/IVDRegulatoryAssistance/ ucm124105.htm.
10. FDA Executive Summary, Molecular and Clinical Genetics Panel, 8 & 9 March, 2011. 2011 [23 July 23 2012]. http://www.fda.gov/downloads/ AdvisoryCommittees?CommitteesMeetingMaterials/MedicalDevices/ MedicalDevicesAdvisoryCommittee/MolecularandClinicalGeneticsPanel/ UCM245660.pdf.
11. Digital Imaging and Communications in Medicine. 2012 [24 August 2012]. medical.nema.org/.
12. University of Washington, Seattle, GeneTests Medical Genetics Information Resource (database online)]. cited 1 August 2012]. http://www.ncbi.nlm.nih.gov/ sites/GeneTests. Note: new website under construction June 2013 at www. genetests.org
13. Eng C, Sharp RR. Bioethical and clinical dilemmas of direct-to-consumer personal genomic testing: the problem of misattributed equivalence. Sci Transl Med 2010;2:17cm5.
14. Edelman E, Eng C. A practical guide to interpretation and clinical application of personal genomic screening. BMJ (Clinical Research edn) 2009;339:b4253.
15. National Center for Biotechnology Information (NCBI). [22 July 2012]. http://www. ncbi.nlm.nih.gov.
16. Napoli M, Nanni M, Cimarra S, et al. Picture archiving and communication in radiology. Rays 2003;28:73-81.
17. NLM. Genetics Home Reference. [9 April 2013]. http://ghr.nlm.nih.gov/ glossary=personalizedmedicine.
18. NIH. Department of Health and Human Services Secretary's Advisory Committee on Genetic Testing. 2008 [7 July 2012]. http://oba.od.nih.gov/SACGHS/ sacghs_documents.html.
19. Fabsitz RR, McGuire A, Sharp RR, et al. Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group. Circ Cardiovasc Genet 2010;3:574-80.
20. Haga SB, Beskow LM. Ethical, legal, and social implications of biobanks for genetics research. Adv Genet 2008;60:505-44.
21. Kohane IS, Masys DR, Altman RB. The incidentalome: a threat to genomic medicine. JAMA 2006;296:212-15.
22. Wolf SM. Introduction: the challenge of incidental findings. J Law Med Ethics 2008;36:216-18.
23. Wolf SM, Paradise J, Caga-anan C. The law of incidental findings in human subjects research: establishing researchers' duties. J Law Med Ethics 2008;36:361-83, 214.
24. Wolf SM, Lawrenz FP, Nelson CA, et al. Managing incidental findings in human subjects research: analysis and recommendations. J Law Med Ethics 2008;36:219-48, 1.
25. Cho MK. Understanding incidental findings in the context of genetics and genomics. J Law Med Ethics 2008;36:280-5; 12.
26. Dressler LG. Disclosure of research results from cancer genomic studies: state of the science. Clin Cancer Res 2009;15:4270-6.
27. Van Ness B. Genomic research and incidental findings. J Law Med Ethics 2008;36:292-7; 12.
28. Clayton EW. Informed consent and biobanks. J Law Med Ethics 2005; 33:15-21.
29. Hudson KL. Genomics, health care, and society. N Engl J Med 2011;365:1033-41.
30. van Calcar SC, Gleason LA, Lindh H, et al. 2-Methylbutyryl-CoA dehydrogenase deficiency in Hmong infants identified by expanded newborn screen. WMJ 2007;106:12-15.
31. Samuel GN, Jordens CF, Kerridge I. Direct-to-consumer personal genome testing: ethical and regulatory issues that arise from wanting to 'know' your DNA. Intern Med J 2010;40:220-4.
32. Wright CF, Hall A, Zimmern RL. Regulating direct-to-consumer genetic tests: what is all the fuss about? Genet Med 2011;13:295-300.
33. Direct-to-Consumer Genetic Testing. Report of the Secretary's Advisory Committee on Genetics Health and Society, 2010.
34. 23andMe. 2012 [15 July 2012]. http://www.23andme.com.
35. deCODEme. 2012 [cited 2012 July 15 2012]. http://www.decodeme.com.
36. Navigenics. 2012 [cited 2012 July 15 2012]. http://www.navigenics.com.
37. Bunnik EM, Schermer MH, Janssens AC. Personal genome testing: test characteristics to clarify the discourse on ethical, legal and societal issues. BMC Med Ethics 2011;12:11.
38. Udesky L. The ethics of direct-to-consumer genetic testing. Lancet 2010;376:1377-8.
39. US Government Accountability Office. Direct to Consumer Genetic Tests: Misleading Test Results Are Further Complicated by Deceptive Marketing and Other Questionable Practices. 2010 [August 01, 2012]. http://www.gao.gov/ products/GAO.
40. Javitt GH, Stanley E, Hudson K. Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health. Okla Law Rev 2004;57:251-302.
41. Javitt G. Which way for genetic-test regulation? Assign regulation appropriate to the level of risk. Nature 2010;466:817-18.
42. Javitt GH. In search of a coherent framework: options for FDA oversight of genetic tests. Food Drug Law J 2007;62:617-52.
43. Skirton H, Goldsmith L, Jackson L, et al. Direct to consumer genetic testing: a systematic review of position statements, policies and recommendations. Clin Genet 2012;82:210-18.
44. Khoury MJ, McBride CM, Schully SD, et al. The Scientific Foundation for Personal Genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med 2009;11:559-67.
45. Federal Trade Commission. At-Home Genetic Tests: A Healthy Dose of Skepticism May Be the Best Prescription. 2007. 3 August 2012. http://www.ftc.gov/bcp/edu/ pubs/consumer/health/hea02.shtm.
46. Burke W, Pinsky LE, Press NA. Categorizing genetic tests to identify their ethical, legal, and social implications. Am J Med Genet 2001;106:233-40.
47. Robertson JA. The $1000 genome: ethical and legal issues in whole genome sequencing of individuals. Am J Bioeth 2003;3:W-IF1.
48. Fost N. Ethical implications of screening asymptomatic individuals. FASEB J 1992;6:2813-17.
49. Fost N. Ethical issues in genetics. Pediatr Clin North Am 1992;39:79-89.
50. Wilcken B. Ethical issues in genetics. J Paediatr Child Health 2011; 47:668-71.
51. Almond B. Genetic profiling of newborns: ethical and social issues. Nat Rev Genet 2006;7:67-71.
52. Fost N. Genetic diagnosis and treatment. Ethical considerations. Am J Dis Child (1960) 1993;147:1190-5.
53. Rogowski WH, Grosse SD, John J, et al. Points to consider in assessing and appraising predictive genetic tests. J Commun Genet 2010;1:185-94.
54. Heshka JT, Palleschi C, Howley H, et al. A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genet Med 2008;10:19-32.
55. Rothstein MA. Genetic exceptionalism and legislative pragmatism. J Law Med Ethics 2007;35(2 Suppl):59-65.
56. Ross LF. Genetic exceptionalism vs. paradigm shift: lessons from HIV. J Law Med Ethics 2001;29:141-8.
57. McGuire AL, Fisher R, Cusenza P, et al. Confidentiality, privacy, and security of genetic and genomic test information in electronic health records: points to consider. Genet Med 2008;10:495-9.
58. Green MJ, Botkin JR. "Genetic exceptionalism" in medicine: clarifying the differences between genetic and nongenetic tests. Ann Intern Med 2003;138:571-5.
59. Botkin JR. Genetic counseling: making room for beneficence. J Clin Ethics 1995;6:182-4.
60. Moulton B, King JS. Aligning ethics with medical decision-making: the quest for informed patient choice. J Law Med Ethics 2010;38:85-97.
61. Guttmacher AE, Porteous ME, McInerney JD. Educating health-care professionals about genetics and genomics. Nat Rev Genet 2007;8:151-7.
62. Gaissmaier W, Gigerenzer G. Statistical illiteracy undermines informed shared decision making. Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen 2008;102:411-13.
63. Mischler EH, Wilfond BS, Fost N, et al. Cystic fibrosis newborn screening: impact on reproductive behavior and implications for genetic counseling. Pediatrics 1998;102:44-52.
64. Gigerenzer G, Gaissmaier W, Kurz-Milcke E, et al. Helping doctors and patients make sense of health statistics. Psychol Sci Public Interest 2007;8:53-96.
65. Jing X, Kay S, Marley T, et al. Incorporating personalized gene sequence variants, molecular genetics knowledge, and health knowledge into an EHR prototype based on the Continuity of Care Record standard. J Biomed Inform 2012;45:82-92.
66. Green MJ, McInerney AM, Biesecker BB, et al. Education about genetic testing for breast cancer susceptibility: patient preferences for a computer program or genetic counselor. Am J Med Genet 2001;103:24-31.
67. Green MJ, Fost N. An interactive computer program for educating and counseling patients about genetic susceptibility to breast cancer. J Cancer Educ 1997;12:204-8.
68. Green MJ, Biesecker BB, McInerney AM, et al. An interactive computer program can effectively educate patients about genetic testing for breast cancer susceptibility. Am J Med Genet 2001;103:16-23.
69. Green ED, Guyer MS. Charting a course for genomic medicine from base pairs to bedside. Nature 2011;470:204-13.
70. Welch BM, Kawamoto K. Clinical decision support for genetically guided personalized medicine: a systematic review. J Am Med Inform Assoc 2013;20:388-400.
71. Green MJ, Fost N. Who should provide genetic education prior to gene testing? Computers and other methods for improving patient understanding. Genet Test 1997;1:131-6.
72. Dabney MK, Huelsman K. Counseling by computer: breast cancer risk and genetic testing. Developed by the University of Wisconsin-Madison Department of Medicine and the Program in Medical Ethics. Genet Test 2000;4:43-4.
73. US Department of Health and Human Services. Office for Civil Rights, Health Information Privacy, Understanding HIPAA Privacy]. 30 July 2012]. http://www.hhs. gov/ocr/privacy/.
74. US Equal Employment Opportunity Commission. [cited 1 August 2012]. http:// www.eeoc.gov/laws/statutes/gina.cfm.
75. US Department of Health and Human Services, Healthcare.gov. [1 August 2012]. http://www.healthcare.gov/law/index.html.
76. Klitzman R. Views of discrimination among individuals confronting genetic disease. J Genet Couns 2010;19:68-83.
77. Weng C, Appelbaum P, Hripcsak G, et al. Using EHRs to integrate research with patient care: promises and challenges. J Am Med Inform Assoc 2012; 19:684-7.
78. Wilfond BS, Nolan K. National policy development for the clinical application of genetic diagnostic technologies. Lessons from cystic fibrosis. JAMA 1993;270:2948-54.
79. Wilfond BS, Fost N. The cystic fibrosis gene: medical and social implications for heterozygote detection. JAMA 1990;263:2777-83.
80. Ginsburg GS, Willard HF. Genomic and personalized medicine: foundations and applications. Transl Res 2009;154:277-87.
81. Malinowski MJ. Separating predictive genetic testing from snake oil: regulation, liabilities, and lost opportunities. Jurimetrics 2000;41:23-52.
82. CDC. Office of Public Health Genomics]. August 2012]. http://www.cdc.gov/ genomics/
83. EGAPP Work Group. Evaluation of Genomic Applications in Practice and Prevention. 2012 [20 July 2012]. http://www.egappreviews.org.
84. National Center for Biotechnology Information. Genetic Testing Registry]. 22 July 2012]. http://www.ncbi.nlm.nih.gov/gtr/.
85. Centers for Disease Control and Prevention. Genomic Applications in Practice and Prevention Network. 2012 [21 July 2012]. http://www.cdc.gov/genomics/ translation/GAPPNet.
86. Genomics in Application, Practice, and Prevention Knowledge Base (GAPP KB). [1 August 2012]. http://www.hugenavigator.net/GAPPKB/home.do.
87. Centers for Disease Control and Prevention, the Office of Public Health Genomics, Human Genome Epidemiology Network. [21 July 2012]. http://www.cdc.gov/ genomics/hugenet.
88. Institute of Medicine of the National Academies: Roundtable on Translating Genomic-Based Research for Health. 2012 [cited 2012, 21 July 2012]. http:// www.iom.edu/Activities/Research/GenomicBasedResearch.aspx.
89. Johns Hopkins University, Online Mendelian Inheritance In Man. 2012 [21 July 2012]. http://www.omim.org.
90. PharmGKB. The Pharmacogenomics Knowledgebase. 2012 [cited 2012, 21 July 2012]. http://www.pharmgkb.org.
91. US Department of Health and Human Services Hg. Secretary's Advisory Committee on Heritable Disorders in Newborns and Children [3 January 2013]. http://www. hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders/.
92. Trotter TL, Fleischman AR, Howell RR, et al. Secretary's Advisory Committee on Heritable Disorders in Newborns and Children response to the President's Council on Bioethics report: the changing moral focus of newborn screening. Genet Med 2011;13:301-4.
93. GeneTests: Laboratory Directory. 2012 [cited 21 July 2012]. http://www.ncbi.nlm. nih.gov/sites/GeneTests/lab?db=GeneTests.
94. Force USPST. US Preventive Services Task Force, Methods and Processes 3 January 2013]. http://www.uspreventiveservicestaskforce.org/methods.htm.
95. American Board of Medical Geneticists. 2012 [16 July 2012]. http://www.abmg.org.
96. Genetics Education Training, Report of the Secretary's Advisory Committee on Genetics, Health, and Society. In: Services DoHaH, editor, 2011.
97. American Academy of Family Physicians Core Educational Guidelines: Medical Genetics (2011). 2010, 26 February 2012.
98. Thurston VC, Wales PS, Bell MA, et al. The current status of medical genetics instruction in US and Canadian medical schools. Acad Med 2007; 82:441-5.
99. Burke S, Martyn M, Thomas H, et al. The development of core learning outcomes relevant to clinical practice: identifying priority areas for genetics education for non-genetics specialist registrars. Clin Med 2009;9:49-52.
100. Trinidad SB, Fryer-Edwards K, Crest A, et al. Educational needs in genetic medicine: primary care perspectives. Community Genet 2008;11:160-5.
101. Burke W, Emery J. Genetics education for primary-care providers. Nat Rev Genet 2002;3:561-6.
102. Laberge AM, Fryer-Edwards K, Kyler P, et al. Long-term outcomes of the "Genetics in Primary Care" faculty development initiative. Fam Med 2009;41:266-70.
103. Carroll JC, Rideout AL, Wilson BJ, et al. Genetic education for primary care providers: improving attitudes, knowledge, and confidence. Can Fam Physician 2009;55:e92-9.
104. Bellcross CA, Kolor K, Goddard KA, et al. Awareness and utilization of BRCA1/2 testing among US primary care physicians. Am J Prev Med 2011;40:61-6.
105. Houwink EJ, van Luijk SJ, Henneman L, et al. Genetic educational needs and the role of genetics in primary care: a focus group study with multiple perspectives. BMC Fam Pract 2011;12:5.
106. Wideroff L, Vadaparampil ST, Greene MH, et al. Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. Am J Med Genet 2005;42:749-55.
107. Fiks AG. Designing computerized decision support that works for clinicians and families. Curr Probl Pediatr Adolesc Health Care 2011;41:60-88.
108. Garg AX, Adhikari NK, McDonald H, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA 2005;293:1223-38.
109. Emery J, Morris H, Goodchild R, et al. The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care. Br J Cancer 2007;97:486-93.
110. Acheson LS, Stange KC, Zyzanski S. Clinical genetics issues encountered by family physicians. Genet Med 2005;7:501-8.
111. Gigerenzer G. Collective statistical illiteracy: a cross-cultural comparison with probabilistic national samples: comment on "Statistical Numeracy for Health". Arch Intern Med 2010;170:468.
112. Garfield J, Ben-Zvi D. How students learn statistics revisited: a current review of research on teaching and learning statistics. Int Stat Rev 2007;75:372-96.
113. Kuehn BM. NIH shifts focus from sequencing genes to fostering clinical applications. JAMA 2012;307:132.
114. Schrijver I, Aziz N, Farkas DH, et al. Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology. J Mol Diagn 2012;14:525-40.
115. Masys DR, Jarvik GP, Abernethy NF, et al. Technical desiderata for the integration of genomic data into Electronic Health Records. J Biomed Inform 2012;45:419-22.
116. Health Level 7 International-Clinical Genomics. [28 March 2013]. http://www. hl7.org/Special/committees/clingenomics/overview.cfm.
117. HL7 Version 2 Implementation Guide: Clinical Genomics; Fully LOINC-Qualified Genetic Variation Model (US Realm). [1 September 2012].
118. Melton GB, Raman N, Chen ES, et al. Evaluation of family history information within clinical documents and adequacy of HL7 clinical statement and clinical genomics family history models for its representation: a case report. J Am Med Inform Assoc 2010;17:337-40.
119. Reese MG, Moore B, Batchelor C, et al. A standard variation file format for human genome sequences. Genome Biol 2010;11:R88.
120. Ullman-Cullere MH, Mathew JP. Emerging landscape of genomics in the Electronic Health Record for personalized medicine. Hum Mutat 2011;32:512-16.
121. Shirts BH, Parker LS. Changing interpretations, stable genes: responsibilities of patients, professionals, and policy makers in the clinical interpretation of complex genetic information. Genet Med 2008;10:778-83.
122. Aronson SJ, Clark EH, Babb LJ, et al. The GeneInsight Suite: a platform to support laboratory and provider use of DNA-based genetic testing. Hum Mutat 2011;32:532-6.
123. Green M, Solnit AJ. Reactions to the threatened loss of a child: a vulnerable child syndrome. Pediatric management of the dying child, Part III. Pediatrics 1964;34:58-66.
124. McGuire AL, Cho MK, McGuire SE, et al. Medicine. The future of personal genomics. Science (New York, NY) 2007;317:1687.
125. Jonsen AR, Durfy SJ, Burke W, et al. The advent of the 'unpatients'. Nat Med 1996;2:622-4.
126. PAAR4Kids). [10 August 2010]. http:///pharmacogenetics.org/paar4kids/research.html.
127. Klitzman R. Exclusion of genetic information from the medical record: ethical and medical dilemmas. JAMA 2010;304:1120-1.
128. Qiao D, Yip WK, Lange C. Handling the data management needs of high-throughput sequencing data: SpeedGene, a compression algorithm for the efficient storage of genetic data. BMC bioinformatics 2012;13:100.
129. Vey G. Differential direct coding: a compression algorithm for nucleotide sequence data. Database: J Biol databases curation 2009;2009:bap013.
130. Schadt EE, Linderman MD, Sorenson J, et al. Computational solutions to large-scale data management and analysis. Nat Rev Genet 2010;11:647-57.
131. Stein LD. The case for cloud computing in genome informatics. Genome Biol 2010;11:207.
132. Baker M. Next-generation sequencing: adjusting to data overload. Nat Methods 2010;7:495-9.
133. Giniat EJ. Cloud computing: innovating the business of health care. Healthc Financ Manage 2011;65:130-1.
134. Dudley JT, Pouliot Y, Chen R, et al. Translational bioinformatics in the cloud: an affordable alternative. Genome Med 2010;2:51.
135. Klein CA. Cloudy confidentiality: clinical and legal implications of cloud computing in health care. J Am Acad Psychiatry Law 2011;39:571-8.
136. Schweitzer EJ. Reconciliation of the cloud computing model with US federal electronic health record regulations. J Am Med Inform Assoc 2012;19:161-5.
137. Taylor RC. An overview of the Hadoop/MapReduce/HBase framework and its current applications in bioinformatics. BMC Bioinformatics 2010;11(Suppl 12):S1.
138. Qiu J, Ekanayake J, Gunarathne T, et al. Hybrid cloud and cluster computing paradigms for life science applications. BMC Bioinformatics 2010;11:S3.
139. Baker M. Genome interpreter vies for place in clinical market. Nature 2012;490:157.
140. Arnason V. Coding and consent: moral challenges of the database project in Iceland. Bioethics 2004;18:27-49.
141. Clayton EW, Smith M, Fullerton SM, et al. Confronting real time ethical, legal, and social issues in the Electronic Medical Records and Genomics (eMERGE) Consortium. Genet Med 2010;12:616-20.
142. McGuire AL, Basford M, Dressler LG, et al. Ethical and practical challenges of sharing data from genome-wide association studies: the eMERGE Consortium experience. Genome Res 2011;21:1001-7.
143. Malin BA. An evaluation of the current state of genomic data privacy protection technology and a roadmap for the future. J Am Med Inform Assoc 2005;12:28-34.
144. Angrist M. Genetic privacy needs a more nuanced approach. Nature 2013;494:7.
145. Lowrance WW, Collins FS. Ethics, Identifiability in genomic research. Science (New York, NY) 2007;317:600-2.
146. Gymrek M, McGuire AL, Golan D, et al. Identifying Personal Genomes by Surname Inference. Science (New York, NY) 2013;339:321-4.
147. Presidential Commission for the Study of Bioethical: Privacy and Progress in Whole Genome Sequencing. 2012 [14 October 2012]. http://www.bioethics,gov/cms/sites/ default/files/PrivacyProgress508.pdf.
148. Bloomrosen M, Detmer D. Advancing the framework: use of health data - a report of a working conference of the American Medical Informatics Association. J Am Med Inform Assoc 2008;15:715-22.
149. Saltz J, Oster S, Hastings S, et al. caGrid: design and implementation of the core architecture of the cancer biomedical informatics grid. Bioinformatics 2006;22:1910-16.
150. Murphy SN, Mendis M, Hackett K, et al. Architecture of the open-source clinical research chart from Informatics for Integrating Biology and the Bedside. AMIA Annu Symp Proc 2007:548-52.
151. Lowe HJ, Ferris TA, Hernandez PM, et al. STRIDE-An integrated standards-based translational research informatics platform. AMIA Annu Symp Proc 2009;2009:391-5.
152. Kamal J, Liu J, Ostrander M, et al. Information warehouse-a comprehensive informatics platform for business, clinical, and research applications. AMIA Annu Symp Proc 2010;2010:452-6.
153. Louie B, Mork P, Martin-Sanchez F, et al. Data integration and genomic medicine. J Biomed Inform 2007;40:5-16.